Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon®, Enlon® and Reversol®.
Clinical uses
Because its duration of action is only about 10 minutes, edrophonium is used to differentiate
myasthenic crisis from
cholinergic crisis. In myasthenic crisis, where a person is not able to produce enough
neuromuscular stimulation, edrophonium will reduce the muscle weakness. In a cholinergic crisis, where a person has too much
neuromuscular stimulation, edrophonium will make the muscle weakness worse.
Sources
- Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
- Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4
More on
[ Edrophonium ]